ARIES HM III

Antiplatelet Removal and HemocompatIbility EventS with the HeartMate 3 Pump (Prevention of thrombus formation and hemocompatibility when using the HeartMate 3 pump)

Principal Investigator: Director of Surgery and Science, Doctor of Medical Sciences, Associate Professor - Yuri Pya.

Clinical Trial Objective:

To evaluate the safety and efficacy of an antithrombotic therapy regimen without the use of antiplatelet agents in patients with severe heart failure who have been installed with the HM3 system of circulatory support and maintenance of left ventricular function.